ANI Pharmaceuticals, Inc.ANIPNASDAQ
Loading
Cash Generation ExpandingExpanding
Percentile Rank100
5Y CAGR+64.7%
Studio
Year-over-Year Change

Cash generated from core business operations

5Y CAGR
+64.7%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
12.1x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$185.22M+189.3%
2024$64.02M-46.2%
2023$118.96M+481.2%
2022$-31.20M-1039.3%
2021$3.32M-78.2%
2020$15.27M-66.5%
2019$45.63M-32.0%
2018$67.07M+70.2%
2017$39.42M+43.5%
2016$27.47M-